CVE-2022-40745

IBM Aspera Faspex information disclosure

At a glance

Severity: MEDIUM 5.5
EPSS: EPSS 0.14 % · percentile 3 (2026-10-27)
State: PUBLISHED
Published: 2024-04-19
Updated: 2024-08-03
Assigner: ibm
NVD status: Modified

Description

IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to obtain sensitive information due to weaker than expected security. IBM X-Force ID: 236452.

Scores

Version	Score	Vector	Scored by
CVSS 3.1	MEDIUM 5.5	CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N	ibm
CVSS 3.1	MEDIUM 5.5	CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N	NVD · psirt@us.ibm.com (Secondary)
CVSS 3.1	MEDIUM 5.5	CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N	NVD · nvd@nist.gov (Primary)

Weaknesses (CWE)

CWE-326

European references

ENISA EUVD · EUVD-2022-44013
GCVE · GCVE-0-2022-40745

Affected configurations (NVD CPE)

cpe:2.3:a:ibm:aspera_faspex:*:*:*:*:*:*:*:* ≥ 5.0.0 ≤ 5.0.7

Affected products

Product	Versions
IBM · Aspera Faspex	affected 5.0.0 ≤ 5.0.7

References

Sources

Source	Licence
CVE List (CVEProject cvelistV5)	CVE Program Terms of Use
EPSS (FIRST.org)	FIRST — attribution requested
ENISA EUVD	ENISA — reproduction authorised, source acknowledged
NVD (NIST) via fkie-cad/nvd-json-data-feeds	Public domain — this product uses data from the NVD API but is not endorsed or certified by the NVD